Bionik Labo Stock Price, News & Analysis
Company Description
Bionik Labo (OTC Link: BNKL) is a publicly traded medical care facilities company in the Healthcare sector. The company has a market capitalization of $1.2K.
BNKL stock has gained 0.0% over the past year. Shares last traded at $0.0000.
On a trailing twelve-month basis, Bionik Labo reported revenue of $1.8M with net income of -$4.9M and diluted earnings per share of $-0.72. The company operates at a net profit margin of -274.0%.
This page provides a comprehensive overview of BNKL stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
Bionik Labo (BNKL) stock last traded at $0.0000. At a market capitalization of $1.2K, BNKL is classified as a micro-cap stock with approximately 12.5M shares outstanding.
Latest News
Bionik Labo has 10 recent news articles. Of the recent coverage, 1 article coincided with positive price movement and 1 with negative movement. Key topics include partnership, acquisition, earnings, conferences, management. View all BNKL news →
SEC Filings
Financial Highlights
Bionik Labo generated $1.8M in revenue over the trailing twelve months, retaining a 54.8% gross margin, operating income reached -$4.8M (-267.3% operating margin), and net income was -$4.9M, reflecting a -274.0% net profit margin. Diluted earnings per share stood at $-0.72. The company generated -$3.4M in operating cash flow. With a current ratio of 1.20, the company maintains adequate short-term liquidity.
Upcoming Events
Short Interest History
Days to Cover History
BNKL Company Profile & Sector Positioning
Bionik Labo (BNKL) operates in the Medical Care Facilities industry within the broader Healthcare sector and is listed on the OTC Link.
Investors comparing BNKL often look at related companies in the same sector, including Skylight Health Group Inc (SLHGF), Ati Physical Therapy Inc (ATIP), Syra Health (SYRA), Clearday Inc (CLRD), and ARBORETA HEALTHCARE INC (ARBH). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate BNKL's relative position within its industry.